Sign Out
Cilostazol (Cylos) is indicated for the improvement of the maximal and pain-free walking distances in patients with intermittent claudication, who do not have rest pain and who do not have evidence of peripheral tissue necrosis.
Cilostazol (Cylos) is for second-line use, in patients for whom lifestyle modifications (including stopping smoking and supervised exercise programs) and other appropriate interventions have failed to sufficiently improve their intermittent claudication symptoms.
